Lagta hi fail ho Gaya 10 may 1 good hota hi Jo milta nahi jo mil jata hi paisa kha jata hi" Innovative tayres and tube Ltd. " Mayra sub paisa kha Gaya, be careful SMEs.
PAR is smaller issue and hence it is going to subscribe heavily. Company is good and sub fig are going to be excellent so considering size and gain PAR is better choice.
Dear Dinesh, Priyansh Small Par Drugs and chemicals Issue opens 3 to 8 price 51 Lot 2000 shares Issue size 8.5 Cr Nse Emerge. LM Pantamoth Book Value is 65 Client includes Pfizer, United phos Networth is 29 Cr. Total Debt 11 Cr. 20 years experience in API and Fine Chemical Products. Gujarat Based Company. Be ready. Finally Pantamoth issue opening.
On comparing audited financials of both Par Drugs and Cian Healthcare, EBIDTA margin of Par drugs is 10.77% whereas CIAN has EBIDTA of 21.34%, PBT magin of Par Drugs is 7.08% and whereas CIAN has PBT margin of 14.41% and PAT margin of Par Drugs is 5.19% whereas Cian has PAT margin of 10.54%.
On comparing the above profitability ratios and other fundamentals, it seems Cian has far more growth potential as compared to Par Drugs.
Completely agree with @dhanaji joshi. Be it EBIDTA, PBT, PAT or financials, Par Drugs can not really compared with Cian. Cian has way more potential and growth as well as future prospects as compared to Par Drugs.
@ Dhanaji and Deep ji first Comments by your side aapko btana chahta hu SME me fundamentals nhi dekhe jate h Only LM and Subscription data dekha jata h Par drug will give good listing gain then Cian healthcare Ek LM hero h to dusra LM zero h
I would like to make it easy for you, SME works on Fundamentals and Intermediaries equally. Talking about subscription, lets have a say on the last day of Issue for both the IPOs. Also, I would really like to know on what basis do you call any LM Hero or Zero? And do you give a Hero or Zero certificate to any LM? If yes, please tell me the cost for the same?
Everything ok. EBIDTA. PBT, PAT all are far better than Par. Human being can live with out leg or hand or something. But cannot live without heart. Heart is like Book Value. Cian Book value is 13 whereas Par book value is 65. Par came at Rs.51 so it left some thing for retail investors. So it sailed through easily. Cian Book value is 13 but issue came at 65. So it fails at first attempt and issue extended till 15th.
23.8. medge| Link| Bookmark|
May 13, 2019 10:22:29 AM
IPO Guru (1300+ Posts, 1900+ Likes)
Thank you Sir, you have explained very nicely. Can we bid at 59 price?
Valuation uncomfortable Margin seems to be inflated Promoter taking Money out of issue. ( Restructuring can be done prelisting as well) Im going to avoid this
The Company is promoted by Suraj Zanwar and Kavita Zanwar. The Advisory and Strategy Board of Company consists Dr. Arun Kumar Khanna (Renowned name in Pharma Industry), Mr. Anoop Sood (Ex President Marketing- Emcure Pharmaceuticals Limited) and CA Mohit Dhand.